{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:51:33Z","timestamp":1781895093837,"version":"3.54.5"},"publisher-location":"Cham","reference-count":83,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030430924","type":"print"},{"value":"9783030430931","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-43093-1_3","type":"book-chapter","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T20:02:38Z","timestamp":1592942558000},"page":"39-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Iron in the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Driton","family":"Vela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"eaaq1011","DOI":"10.1126\/scitranslmed.aaq1011","volume":"10","author":"P DelNero","year":"2018","unstructured":"DelNero P, Hopkins BD, Cantley LC, Fischbach C (2018) Cancer metabolism gets physical. Sci Transl Med 10:eaaq1011","journal-title":"Sci Transl Med"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","volume":"38","author":"SV Torti","year":"2018","unstructured":"Torti SV, Manz DH, Paul BT, Blanchette-Farra N, Torti FM (2018) Iron and Cancer. Annu Rev Nutr 38:97\u2013125","journal-title":"Annu Rev Nutr"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/nyas.13008","volume":"1368","author":"DH Manz","year":"2016","unstructured":"Manz DH, Blanchette NL, Paul BT, Torti FM, Torti SV (2016) Iron and cancer: recent insights. Ann N Y Acad Sci 1368:149\u2013161","journal-title":"Ann N Y Acad Sci"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.redox.2017.08.015","volume":"14","author":"S Masaldan","year":"2018","unstructured":"Masaldan S, Clatworthy SAS, Gamell C, Meggyesy PM, Rigopoulos AT, Haupt S et al (2018) Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox Biol 14:100\u2013115","journal-title":"Redox Biol"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/iub.1602","volume":"69","author":"M S\u00e1nchez","year":"2017","unstructured":"S\u00e1nchez M, Sabio L, G\u00e1lvez N, Capdevila M, Dominguez-Vera JM (2017) Iron chemistry at the service of life. IUBMB Life 69:382\u2013388","journal-title":"IUBMB Life"},{"key":"3_CR6","first-page":"107","volume":"76","author":"Y Ebina","year":"1986","unstructured":"Ebina Y, Okada S, Hamazaki S, Ogino F, Li JL, Midorikawa O (1986) Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst 76:107\u2013113","journal-title":"J Natl Cancer Inst"},{"key":"3_CR7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043403","volume":"7","author":"S Akatsuka","year":"2012","unstructured":"Akatsuka S, Yamashita Y, Ohara H, Liu Y-T, Izumiya M, Abe K et al (2012) Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS One 7:e43403","journal-title":"PLoS One"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"33911","DOI":"10.1074\/jbc.M806432200","volume":"283","author":"F Zhang","year":"2008","unstructured":"Zhang F, Wang W, Tsuji Y, Torti SV, Torti FM (2008) Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest. J Biol Chem 283:33911\u201333918","journal-title":"J Biol Chem"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"C728","DOI":"10.1152\/ajpcell.00322.2015","volume":"310","author":"P Chanvorachote","year":"2016","unstructured":"Chanvorachote P, Luanpitpong S (2016) Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells. Am J Physiol Cell Physiol 310:C728\u2013C739","journal-title":"Am J Physiol Cell Physiol"},{"key":"3_CR10","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.273","volume":"50","author":"D Vela","year":"2018","unstructured":"Vela D, Vela-Gaxha Z (2018) Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications. Exp Mol Med 50:e436","journal-title":"Exp Mol Med"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"e11629","DOI":"10.1371\/journal.pone.0011629","volume":"5","author":"S Straud","year":"2010","unstructured":"Straud S, Zubovych I, de Brabander JK, Roth MG (2010) Inhibition of iron uptake is responsible for differential sensitivity to V-ATPase inhibitors in several cancer cell lines. PLoS One 5:e11629","journal-title":"PLoS One"},{"key":"3_CR12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22693","volume":"6","author":"AL Miles","year":"2017","unstructured":"Miles AL, Burr SP, Grice GL, Nathan JA (2017) The vacuolar-ATPase complex and assembly factors, TMEM199 and CCDC115, control HIF1\u03b1 prolyl hydroxylation by regulating cellular iron levels. elife 6:e22693","journal-title":"elife"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/ijms20010095","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yu L, Ding J, Chen Y (2019) Iron metabolism in cancer. Int J Mol Sci 20:95","journal-title":"Int J Mol Sci"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/01635580701308265","volume":"58","author":"DL Ornstein","year":"2007","unstructured":"Ornstein DL, Zacharski LR (2007) Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells. Nutr Cancer 58:115\u2013126","journal-title":"Nutr Cancer"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1158\/0008-5472.CAN-13-1224","volume":"74","author":"W Wang","year":"2014","unstructured":"Wang W, Deng Z, Hatcher H, Miller LD, Di X, Tesfay L et al (2014) IRP2 regulates breast tumor growth. Cancer Res 74:497\u2013507","journal-title":"Cancer Res"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41598-018-35947-7","volume":"9","author":"KR Babu","year":"2019","unstructured":"Babu KR, Muckenthaler MU (2019) miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma. Sci Rep 9:1518","journal-title":"Sci Rep"},{"key":"3_CR17","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1541-7786.MCR-14-0074","volume":"12","author":"IRD Johnson","year":"2014","unstructured":"Johnson IRD, Parkinson-Lawrence EJ, Shandala T, Weigert R, Butler LM, Brooks DA (2014) Altered endosome biogenesis in prostate cancer has biomarker potential. Mol Cancer Res 12:1851\u20131862","journal-title":"Mol Cancer Res"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.canlet.2016.08.006","volume":"381","author":"B Wang","year":"2016","unstructured":"Wang B, Zhang J, Song F, Tian M, Shi B, Jiang H et al (2016) EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1. Cancer Lett 381:331\u2013340","journal-title":"Cancer Lett"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000163935","volume":"63","author":"J Kovar","year":"1995","unstructured":"Kovar J, Naumann PW, Stewart BC, Kemp JD (1995) Differing sensitivity of non-hematapoietic human tumors to synergistic anti-transferrin receptor monoclonal antibodies and deferoxamine in vitro. Pathobiology 63:65\u201370","journal-title":"Pathobiology"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cmet.2016.07.015","volume":"24","author":"X Xue","year":"2016","unstructured":"Xue X, Ramakrishnan SK, Weisz K, Triner D, Xie L, Attili D et al (2016) Iron uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling to promote colorectal tumorigenesis. Cell Metab 24:447\u2013461","journal-title":"Cell Metab"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1158\/1541-7786.MCR-11-0281","volume":"10","author":"IM Gomes","year":"2012","unstructured":"Gomes IM, Maia CJ, Santos CR (2012) STEAP proteins: from structure to applications in cancer therapy. Mol Cancer Res 10:573\u2013587","journal-title":"Mol Cancer Res"},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.15252\/emmm.201404181","volume":"7","author":"Y Jin","year":"2015","unstructured":"Jin Y, Wang L, Qu S, Sheng X, Kristian A, M\u00e6landsmo GM et al (2015) STAMP 2 increases oxidative stress and is critical for prostate cancer. EMBO Mol Med 7:315\u2013331","journal-title":"EMBO Mol Med"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1002\/cam4.1594","volume":"7","author":"B Whitton","year":"2018","unstructured":"Whitton B, Okamoto H, Packham G, Crabb SJ (2018) Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer. Cancer Med 7:3800\u20133811","journal-title":"Cancer Med"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.3892\/or.2016.5167","volume":"36","author":"X Zhang","year":"2016","unstructured":"Zhang X, Hua L, Yan D, Zhao F, Liu J, Zhou H et al (2016) Overexpression of PCBP2 contributes to poor prognosis and enhanced cell growth in human hepatocellular carcinoma. Oncol Rep 36:3456\u20133464","journal-title":"Oncol Rep"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1128\/MCB.00104-16","volume":"36","author":"F Li","year":"2016","unstructured":"Li F, Bullough KZ, Vashisht AA, Wohlschlegel JA, Philpott CC (2016) Poly(rC)-binding protein 2 regulates hippo signaling to control growth in breast epithelial cells. Mol Cell Biol 36:2121\u20132131","journal-title":"Mol Cell Biol"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/2211-5463.12408","volume":"8","author":"C Chen","year":"2018","unstructured":"Chen C, Lei J, Zheng Q, Tan S, Ding K, Yu C (2018) Poly(rC) binding protein 2 (PCBP2) promotes the viability of human gastric cancer cells by regulating CDK2. FEBS Open Bio 8:764\u2013773","journal-title":"FEBS Open Bio"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"82231","DOI":"10.18632\/oncotarget.19288","volume":"8","author":"Z Deng","year":"2017","unstructured":"Deng Z, Manz DH, Torti SV, Torti FM (2017) Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth. Oncotarget 8:82231\u201382243","journal-title":"Oncotarget"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"1600711","DOI":"10.1183\/13993003.00711-2016","volume":"49","author":"H Khiroya","year":"2017","unstructured":"Khiroya H, Moore JS, Ahmad N, Kay J, Woolnough K, Langman G et al (2017) IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer. Eur Respir J 49:1600711","journal-title":"Eur Respir J"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/cas.13234","volume":"108","author":"RD Horniblow","year":"2017","unstructured":"Horniblow RD, Bedford M, Hollingworth R, Evans S, Sutton E, Lal N et al (2017) BRAF mutations are associated with increased iron regulatory protein-2 expression in colorectal tumorigenesis. Cancer Sci 108:1135\u20131143","journal-title":"Cancer Sci"},{"key":"3_CR30","first-page":"1426","volume":"2012","author":"DM Ward","year":"1823","unstructured":"Ward DM, Kaplan J (1823) Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta, Mol Cell Res 2012:1426\u20131433","journal-title":"Biochim Biophys Acta, Mol Cell Res"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"43ra56","DOI":"10.1126\/scitranslmed.3001127","volume":"2","author":"ZK Pinnix","year":"2010","unstructured":"Pinnix ZK, Miller LD, Wang W, D\u2019Agostino R, Kute T, Willingham MC et al (2010) Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med 2:43ra56","journal-title":"Sci Transl Med"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/ars.2017.7023","volume":"30","author":"Z Deng","year":"2019","unstructured":"Deng Z, Manz DH, Torti SV, Torti FM (2019) Effects of ferroportin-mediated iron depletion in cells representative of different histological subtypes of prostate cancer. Antioxid Redox Signal 30:1043\u20131061","journal-title":"Antioxid Redox Signal"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.cellsig.2014.07.029","volume":"26","author":"S Zhang","year":"2014","unstructured":"Zhang S, Chen Y, Guo W, Yuan L, Zhang D, Xu Y et al (2014) Disordered hepcidin-ferroportin signaling promotes breast cancer growth. Cell Signal 26:2539\u20132550","journal-title":"Cell Signal"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1158\/0008-5472.CAN-14-3804","volume":"75","author":"Z Gu","year":"2015","unstructured":"Gu Z, Wang H, Xia J, Yang Y, Jin Z, Xu H et al (2015) Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation. Cancer Res 75:2211\u20132221","journal-title":"Cancer Res"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMBS, Kroemer G, Galluzzi L (2018) Mitochondrial metabolism and cancer. Cell Res 28:265\u2013280","journal-title":"Cell Res"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"e13324","DOI":"10.1111\/apha.13324","volume":"228","author":"D Vela","year":"2019","unstructured":"Vela D (2019) Keeping heart homeostasis in check through the balance of iron metabolism. Acta Physiol 228:e13324. https:\/\/doi.org\/10.1111\/apha.13324","journal-title":"Acta Physiol"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"38343","DOI":"10.1038\/srep38343","volume":"6","author":"M Frykn\u00e4s","year":"2016","unstructured":"Frykn\u00e4s M, Zhang X, Bremberg U, Senkowski W, Olofsson MH, Brandt P et al (2016) Iron chelators target both proliferating and quiescent cancer cells. Sci Rep 6:38343","journal-title":"Sci Rep"},{"issue":"Supp. 1","key":"3_CR38","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.freeradbiomed.2018.04.202","volume":"120","author":"C Sandoval-Acu\u00f1a","year":"2018","unstructured":"Sandoval-Acu\u00f1a C, Tomkova V, Cardenas NT, Neuzil J, Repkova K, Stursa J et al (2018) Mitochondrial iron chelation as a novel anti-cancer strategy. Free Radic Biol Med 120(Supp. 1):S61","journal-title":"Free Radic Biol Med"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.283.5402.676","volume":"283","author":"KJ Wu","year":"1999","unstructured":"Wu KJ, Polack A, Dalla-Favera R (1999) Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283:676\u2013679","journal-title":"Science"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1016\/S0021-9258(18)53172-0","volume":"268","author":"Y Tsuji","year":"1993","unstructured":"Tsuji Y, Kwak E, Saika T, Torti SV, Torti FM (1993) Preferential repression of the H subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts. J Biol Chem 268:7270\u20137275","journal-title":"J Biol Chem"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/cancers3010994","volume":"3","author":"T Ozaki","year":"2011","unstructured":"Ozaki T, Nakagawara A (2011) Role of p53 in cell death and human cancers. Cancers 3:994\u20131013","journal-title":"Cancers"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"84893","DOI":"10.18632\/oncotarget.12753","volume":"7","author":"X Jiang","year":"2016","unstructured":"Jiang X, Zhang C, Qi S, Guo S, Chen Y, Du E et al (2016) Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress. Oncotarget 7:84893\u201384906","journal-title":"Oncotarget"},{"key":"3_CR43","first-page":"1867","volume":"47","author":"JL Li","year":"1987","unstructured":"Li JL, Okada S, Hamazaki S, Ebina Y, Midorikawa O (1987) Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 47:1867\u20131869","journal-title":"Cancer Res"},{"key":"3_CR44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3389\/fonc.2018.00547","volume":"8","author":"D Vela","year":"2018","unstructured":"Vela D (2018) Iron metabolism in prostate cancer; from basic science to new therapeutic strategies. Front Oncol 8:547","journal-title":"Front Oncol"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H (2019) Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol 12:76","journal-title":"J Hematol Oncol"},{"key":"3_CR46","first-page":"523","volume":"3","author":"K Gollapudi","year":"2013","unstructured":"Gollapudi K, Galet C, Grogan T, Zhang H, Said JW, Huang J et al (2013) Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy. Am J Cancer Res 3:523\u2013529","journal-title":"Am J Cancer Res"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/eji.200939889","volume":"40","author":"S Recalcati","year":"2010","unstructured":"Recalcati S, Locati M, Marini A, Santambrogio P, Zaninotto F, De Pizzol M et al (2010) Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol 40:824\u2013835","journal-title":"Eur J Immunol"},{"key":"3_CR48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2017.03.018","volume":"120","author":"M Jung","year":"2017","unstructured":"Jung M, Mertens C, Bauer R, Rehwald C, Br\u00fcne B (2017) Lipocalin-2 and iron trafficking in the tumor microenvironment. Pharmacol Res 120:146\u2013156","journal-title":"Pharmacol Res"},{"key":"3_CR49","volume":"7","author":"C Mertens","year":"2018","unstructured":"Mertens C, Mora J, \u00d6ren B, Grein S, Winslow S, Scholich K et al (2018) Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment. Onco Targets Ther 7:e1408751","journal-title":"Onco Targets Ther"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"ra64","DOI":"10.1126\/scisignal.aaf3241","volume":"9","author":"M Jung","year":"2016","unstructured":"Jung M, \u00d6ren B, Mora J, Mertens C, Dziumbla S, Popp R et al (2016) Lipocalin 2 from macrophages stimulated by tumor cell-derived sphingosine-1-phosphate promotes lymphangiogenesis and tumor metastasis. Sci Signal 9:ra64","journal-title":"Sci Signal"},{"key":"3_CR51","volume":"11","author":"C Mertens","year":"2016","unstructured":"Mertens C, Akam EA, Rehwald C, Br\u00fcne B, Tomat E, Jung M (2016) Intracellular iron chelation modulates the macrophage iron phenotype with consequences on tumor progression. PLoS One 11:e0166164","journal-title":"PLoS One"},{"key":"3_CR52","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.18632\/oncotarget.27089","volume":"10","author":"S Prill","year":"2019","unstructured":"Prill S, Rebstock J, Tennemann A, K\u00f6rfer J, S\u00f6nnichsen R, Thieme R et al (2019) Tumor-associated macrophages and individual chemo-susceptibility are influenced by iron chelation in human slice cultures of gastric cancer. Oncotarget 10:4731\u20134742","journal-title":"Oncotarget"},{"key":"3_CR53","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41598-018-37408-7","volume":"9","author":"A Leftin","year":"2019","unstructured":"Leftin A, Ben-Chetrit N, Joyce JA, Koutcher JA (2019) Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy. Sci Rep 9:857","journal-title":"Sci Rep"},{"key":"3_CR54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2018.07.015","volume":"133","author":"S Recalcati","year":"2019","unstructured":"Recalcati S, Gammella E, Cairo G (2019) Dysregulation of iron metabolism in cancer stem cells. Free Radic Biol Med 133:216\u2013220","journal-title":"Free Radic Biol Med"},{"key":"3_CR55","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1038\/onc.2017.11","volume":"36","author":"D Basuli","year":"2017","unstructured":"Basuli D, Tesfay L, Deng Z, Paul B, Yamamoto Y, Ning G et al (2017) Iron addiction: a novel therapeutic target in ovarian cancer. Oncogene 36:4089\u20134099","journal-title":"Oncogene"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1002\/pmic.201200103","volume":"12","author":"D Kanojia","year":"2012","unstructured":"Kanojia D, Zhou W, Zhang J, Jie C, Lo PK, Wang Q et al (2012) Proteomic profiling of cancer stem cells derived from primary tumors of HER2\/Neu transgenic mice. Proteomics 12:3407\u20133415","journal-title":"Proteomics"},{"key":"3_CR57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccell.2015.09.002","volume":"28","author":"DL Schonberg","year":"2015","unstructured":"Schonberg DL, Miller TE, Wu Q, Flavahan WA, Das NK, Hale JS et al (2015) Preferential iron trafficking characterizes glioblastoma stem-like cells. Cancer Cell 28:441\u2013455","journal-title":"Cancer Cell"},{"key":"3_CR58","doi-asserted-by":"crossref","first-page":"98405","DOI":"10.18632\/oncotarget.21846","volume":"8","author":"T Ninomiya","year":"2017","unstructured":"Ninomiya T, Ohara T, Noma K, Katsura Y, Katsube R, Kashima H et al (2017) Iron depletion is a novel therapeutic strategy to target cancer stem cells. Oncotarget 8:98405\u201398416","journal-title":"Oncotarget"},{"key":"3_CR59","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.18632\/oncotarget.14093","volume":"8","author":"Z Rychtarcikova","year":"2017","unstructured":"Rychtarcikova Z, Lettlova S, Tomkova V, Korenkova V, Langerova L, Simonova E et al (2017) Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism. Oncotarget 8:6376\u20136398","journal-title":"Oncotarget"},{"key":"3_CR60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2018.07.009","volume":"53","author":"M El Hout","year":"2018","unstructured":"El Hout M, Dos Santos L, Hama\u00ef A, Mehrpour M (2018) A promising new approach to cancer therapy: targeting iron metabolism in cancer stem cells. Semin Cancer Biol 53:125\u2013138","journal-title":"Semin Cancer Biol"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz T, Kalluri R, Nieto MA, Weinberg RA (2018) EMT in cancer. Nat Rev Cancer 18:128\u2013134","journal-title":"Nat Rev Cancer"},{"key":"3_CR62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/emmm.201100190","volume":"4","author":"W Liu","year":"2012","unstructured":"Liu W, Xing F, Iiizumi-Gairani M, Okuda H, Watabe M, Pai SK et al (2012) N-myc downstream regulated gene 1 modulates Wnt-\u03b2-catenin signalling and pleiotropically suppresses metastasis. EMBO Mol Med 4:93\u2013108","journal-title":"EMBO Mol Med"},{"key":"3_CR63","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.taap.2018.07.017","volume":"356","author":"Z Shan","year":"2018","unstructured":"Shan Z, Wei Z, Shaikh ZA (2018) Suppression of ferroportin expression by cadmium stimulates proliferation, EMT, and migration in triple-negative breast cancer cells. Toxicol Appl Pharmacol 356:36\u201343","journal-title":"Toxicol Appl Pharmacol"},{"key":"3_CR64","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","volume":"16","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H, Enomoto A, Woods SL, Burt AD, Takahashi M, Worthley DL (2019) Cancer-associated fibroblasts in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol 16:282\u2013295","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3_CR65","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12885-019-5462-2","volume":"19","author":"TP Sandberg","year":"2019","unstructured":"Sandberg TP, Stuart MPME, Oosting J, Tollenaar RAEM, Sier CFM, Mesker WE (2019) Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer. BMC Cancer 19:284","journal-title":"BMC Cancer"},{"key":"3_CR66","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1038\/s41388-019-0805-7","volume":"38","author":"L Ippolito","year":"2019","unstructured":"Ippolito L, Morandi A, Taddei ML, Parri M, Comito G, Iscaro A et al (2019) Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer. Oncogene 38:5339\u20135355","journal-title":"Oncogene"},{"key":"3_CR67","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1038\/s41388-018-0243-y","volume":"37","author":"N Blanchette-Farra","year":"2018","unstructured":"Blanchette-Farra N, Kita D, Konstorum A, Tesfay L, Lemler D, Hegde P et al (2018) Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer. Oncogene 37:4013\u20134032","journal-title":"Oncogene"},{"key":"3_CR68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41556-018-0249-2","volume":"21","author":"S Lee","year":"2019","unstructured":"Lee S, Schmitt CA (2019) The dynamic nature of senescence in cancer. Nat Cell Biol 21:94\u2013101","journal-title":"Nat Cell Biol"},{"key":"3_CR69","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/OTT.S127547","volume":"10","author":"T Chen","year":"2017","unstructured":"Chen T, Yang P, Wang H, He ZY (2017) Silence of long noncoding RNA PANDAR switches low-dose curcumin-induced senescence to apoptosis in colorectal cancer cells. Onco Targets Ther 10:483\u2013491","journal-title":"Onco Targets Ther"},{"key":"3_CR70","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.freeradbiomed.2005.11.003","volume":"40","author":"Y Jiao","year":"2006","unstructured":"Jiao Y, Wilkinson J IV, Christine Pietsch E, Buss JL, Wang W, Planalp R et al (2006) Iron chelation in the biological activity of curcumin. Free Radic Biol Med 40:1152\u20131160","journal-title":"Free Radic Biol Med"},{"key":"3_CR71","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden BT (2019) Targeting ferroptosis to iron out cancer. Cancer Cell 35:830\u2013849","journal-title":"Cancer Cell"},{"key":"3_CR72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","volume":"3","author":"SJ Dixon","year":"2019","unstructured":"Dixon SJ, Stockwell BR (2019) The hallmarks of ferroptosis. Annu Rev Cancer Biol 3:35\u201354","journal-title":"Annu Rev Cancer Biol"},{"key":"3_CR73","volume":"7","author":"S Ma","year":"2016","unstructured":"Ma S, Henson ES, Chen Y, Gibson SB (2016) Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis 7:e2307","journal-title":"Cell Death Dis"},{"key":"3_CR74","first-page":"3826","volume":"22","author":"N Geng","year":"2018","unstructured":"Geng N, Shi B-J, Li S-L, Zhong Z-Y, Li Y-C, Xua W-L et al (2018) Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells. Eur Rev Med Pharmacol Sci 22:3826\u20133836","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3_CR75","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nchem.2778","volume":"9","author":"TT Mai","year":"2017","unstructured":"Mai TT, Hama\u00ef A, Hienzsch A, Ca\u00f1eque T, M\u00fcller S, Wicinski J et al (2017) Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat Chem 9:1025\u20131033","journal-title":"Nat Chem"},{"key":"3_CR76","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41419-019-1564-7","volume":"10","author":"S Sui","year":"2019","unstructured":"Sui S, Zhang J, Xu S, Wang Q, Wang P, Pang D (2019) Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells. Cell Death Dis 10:331. https:\/\/doi.org\/10.1038\/s41419-019-1564-7","journal-title":"Cell Death Dis"},{"key":"3_CR77","first-page":"1","volume":"2019","author":"Y Sun","year":"2019","unstructured":"Sun Y, Li C, Feng J, Li Y, Zhai X, Zhang L et al (2019) Ferritinophagic flux activation in CT26 cells contributed to EMT inhibition induced by a novel iron chelator, DpdtpA. Oxid Med Cell Longev 2019:1\u201314","journal-title":"Oxid Med Cell Longev"},{"key":"3_CR78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/path.5104","volume":"246","author":"S Tury","year":"2018","unstructured":"Tury S, Assayag F, Bonin F, Chateau-Joubert S, Servely JL, Vacher S et al (2018) The iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancers. J Pathol 246:103\u2013114","journal-title":"J Pathol"},{"key":"3_CR79","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1158\/0008-5472.CAN-11-1870","volume":"71","author":"LD Miller","year":"2011","unstructured":"Miller LD, Coffman LG, Chou JW, Black MA, Bergh J, D\u2019Agostino R et al (2011) An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res 71:6728\u20136737","journal-title":"Cancer Res"},{"key":"3_CR80","first-page":"8125","volume":"15","author":"R Toshiyama","year":"2018","unstructured":"Toshiyama R, Konno M, Eguchi H, Asai A, Noda T, Koseki J et al (2018) Association of iron metabolic enzyme hepcidin expression levels with the prognosis of patients with pancreatic cancer. Oncol Lett 15:8125\u20138133","journal-title":"Oncol Lett"},{"key":"3_CR81","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.2147\/IJN.S168053","volume":"13","author":"RV Kalaydina","year":"2018","unstructured":"Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR (2018) Recent advances in \u201csmart\u201d delivery systems for extended drug release in cancer therapy. Int J Nanomedicine 13:4727\u20134745","journal-title":"Int J Nanomedicine"},{"key":"3_CR82","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/cgt.2013.9","volume":"20","author":"ER Camp","year":"2013","unstructured":"Camp ER, Wang C, Little EC, Watson PM, Pirollo KF, Rait A et al (2013) Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Ther 20:222\u2013228","journal-title":"Cancer Gene Ther"},{"key":"3_CR83","first-page":"1096","volume-title":"Molecular Therapy","author":"N Senzer","year":"2013","unstructured":"Senzer N, Nemunaitis J, Nemunaitis D, Bedell C, Edelman G, Barve M et al (2013) Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors. In: Molecular Therapy, vol 21. Nature Publishing Group, New York, pp 1096\u20131103"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-43093-1_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T14:28:24Z","timestamp":1616336904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-43093-1_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030430924","9783030430931"],"references-count":83,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-43093-1_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"24 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}